EquityBulls

Latest News

Granules India Reports Strong Q1 FY27 Performance: Net Profit Jumps 59.8% YoY to ₹179.96 Crore
Siyaram Recycling Industries Ltd secures order worth Rs. 2.34 crore
Pace Digitek Establishes Dedicated R&D Center and Collaborates with IISER Pune to Advance Indigenous Energy Storage Research
Cranex Ltd receives LOA for orders worth Rs. 16.03 crores
GE Shipping delivers its 2009 built LR2 Tanker 'Jag Lokesh'

Keywords Selected: USFDA

Stock Report

Glenmark Receives U.S. FDA Approval to Expand the Use of RYALTRIS® Nasal Spray for Children Aged 6 to Less Than 12 Years
Wanbury Limited gets 6 observations from USFDA after cGMP inspection at Tanuku facility
Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg
NATCO receives Tentative Approval for Olaparib Tablets from the U.S. FDA
USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA
Ajanta Pharma Ltd receives EIR from USFDA for Paithan facility
Lupin Receives EIR from U.S. FDA for its Somerset Facility with VAI Classification
US FDA inspection at Glenmark Pharmaceuticals Ltd's manufacturing facility in Goa, India
Completion of US FDA Inspection at Auroactive Pharma Pvt Ltd
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%
Lupin receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
Completion of US FDA Pre-Approval Inspection at Eugia Steriles Private Limited
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
Classification of US FDA Inspection at Unit-III of Eugia Pharma Specialities Ltd, Pashamylaram as OAI
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.05%
USFDA inspection at Cipla Ltd's manufacturing facility in Verna, Goa, India
Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg
Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg
Lupin receives approval from U.S. FDA for Ranluspec™ (ranibizumab) Injection
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
NATCO and Lupin receive approval from U.S. FDA for Eribulin Mesylate Injection
Concord Biotech Ltd receives ANDA approval from USFDA for Mycophenolate Mofetil for Oral Suspension USP
Zydus Therapeutics receives USFDA priority review to NDA for Saroglitazar